Down 50%: Greenrise Global Brands (XCX.CN CNQ) Feb 04 market hours: liquidity risk

The XCX.CN stock price dropped 50.00% to CAD 0.005 on Feb 04 2026 during market hours on CNQ. This move cut the previous close of CAD 0.010 and pushed the share price to its year low. Volume was reported at 0 shares with a 50-day average of 21,793. We review why Greenrise Global Brands Inc. (XCX.CN) fell, the financial ratios, and what Meyka AI’s model projects next.

Market snapshot for XCX.CN stock

Greenrise Global Brands Inc. (XCX.CN) traded on the CNQ exchange in Canada at CAD 0.005. The intraday range was CAD 0.005–0.005 with reported volume 0. Market cap stands near CAD 258,277.00, and shares outstanding total 51,655,400. The 50-day average price is CAD 0.00610, and the 200-day average is CAD 0.00620.

Immediate drivers behind the top loser move

The one-day decline of 50.00% followed heavy selling pressure and sparse trading. Zero reported volume suggests few matched trades and possible stale prints. Negative EPS at -0.03 and a negative PE ratio of -0.17 add selling pressure. In our view, liquidity constraints are the primary short-term catalyst.

Fundamentals and valuation of Greenrise Global Brands Inc.

XCX.CN stock shows weak fundamentals versus the healthcare sector averages. Book value per share is -0.05554 and shareholders’ equity per share is -0.05846. Current ratio sits at 0.00378, signaling constrained short-term liquidity. Enterprise value is CAD 2,857,458.46, which reflects a mismatch with reported market cap.

Technicals, volume and trading metrics for XCX.CN

Technical indicators show muted price action but a strong ADX at 41.16, indicating a strong trend. RSI near 47.31 is neutral. Average volume is 21,793 shares, but today’s reported volume was 0, increasing volatility risk for traders. On thin liquidity, even small orders move price sharply.

Meyka AI rates XCX.CN with a score out of 100

Meyka AI rates XCX.CN with a score of 61.22 out of 100, graded B with a suggestion to HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade is informational only and not financial advice.

Meyka AI forecast and price target implications

Meyka AI’s forecast model projects a one-year price near CAD 0.01931. That implies an upside of 286.20% from CAD 0.005. We present practical near-term targets: a conservative short-term support near CAD 0.005, a recovery target at CAD 0.010, and a 12-month model target CAD 0.01931. Forecasts are model-based projections and not guarantees.

Final Thoughts

XCX.CN stock traded sharply lower during market hours on Feb 04 2026, falling 50.00% to CAD 0.005. The fall appears driven by very thin liquidity and weak fundamentals, including negative EPS of -0.03 and book value per share at -0.05554. Technicals show neutral momentum with ADX strong at 41.16, but zero reported volume raises execution risk for buyers and sellers. Meyka AI’s model projects CAD 0.01931 over the next 12 months, implying 286.20% upside from today’s price, but that projection assumes improved liquidity and execution of business plans. Investors should weigh near-term liquidity risk, negative equity metrics, and sector headwinds in Healthcare in Canada. Meyka AI, our AI-powered market analysis platform, flags the stock as speculative. Forecasts are model based and not guarantees. Monitor trading volume and any company updates before taking a position.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.